It was suggested that FGF21 exerts anti-inflammatory and anti-carcinogenic effects by inhibiting hepatocyte TLR4-IL-17A signaling in the NASH-HCC mouse model, which may prevent the development of HCC. Here, TLR4 is linked to hepatocellular carcinoma.